Challenges remain in determining appropriate sequence of immunotherapy, BRAF/MEK inhibition – Healio
|
Challenges remain in determining appropriate sequence of immunotherapy, BRAF/MEK inhibition
Healio NEW YORK — The optimal sequence of immunotherapy and BRAF/MEK inhibition for the first-line treatment of melanoma has only been evaluated retrospectively and remains to be defined, according to a presenter at HemOnc Today Melanoma and … |
